FJACX
Price
$11.97
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VSCIX
Price
$120.70
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FJACX vs VSCIX

Header iconFJACX vs VSCIX Comparison
Open Charts FJACX vs VSCIXBanner chart's image
Fidelity Series Small Cap Discovery
Price$11.97
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$120.70
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FJACX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FJACX vs. VSCIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FJACX is a Buy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 151B vs. FJACX (1.5B). VSCIX pays higher dividends than FJACX: VSCIX (1.43) vs FJACX (0.99). FJACX was incepted earlier than VSCIX: FJACX (11 years) vs VSCIX (27 years). FJACX is a more actively managed with annual turnover of: 31.00 vs. VSCIX (12.00). FJACX has a lower initial minimum investment than VSCIX: FJACX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 32.13 vs. FJACX (13.07). VSCIX return over 5 years is better than : 59.15 vs. FJACX (6.49).
FJACXVSCIXFJACX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years27 years-
Gain YTD2.80418.40415%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.5B151B1%
Annual Yield % from dividends0.991.4369%
Returns for 1 year13.0732.1341%
Returns for 3 years-18.837.14-264%
Returns for 5 years6.4959.1511%
Returns for 10 years20.44128.6316%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHVS20.150.31
+1.56%
Pharvaris NV
BOX34.670.43
+1.26%
BOX
TSCO278.75-0.44
-0.16%
Tractor Supply Company
XGN2.75-0.04
-1.43%
Exagen
AMTX4.11-0.51
-11.04%
Aemetis